ABRO 1,RESITON GINGIVA,PRIME 和 THERAPON TRANSPA
K号: K200676 · 2020-07-08
广告
器械摘要
常见问题
What is the ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA?
ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA is a medical device that received FDA 510(k) clearance on 2020-07-08. The listed applicant is Zirkonzahn Srl. The 510(k) number is K200676.
When did ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA receive FDA 510(k) clearance?
ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA received FDA 510(k) clearance on 2020-07-08, under 510(k) number K200676.
Who is the listed applicant for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA?
The FDA 510(k) record lists Zirkonzahn Srl as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA?
The FDA product code for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA is EBG.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Zirkonzahn Srl为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:EBG)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告